Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Savior LifetecROCO:4167 -0.24%68 PB Ratio is 1.69 as of Jul. 14, 2026, which is 22% below its 10-year median of 2.16. GuruFocus rates ROCO:4167 with a GF Score™ of 68/100 and a GF Value™ of NT$20.31 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,228 Biotechnology companies, Savior Lifetec ranks better than 69.06% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-14), Savior Lifetec's share price is NT$20.60. Savior Lifetec's Book Value per Share for the quarter that ended in Dec. 2025 was NT$12.18. Hence, Savior Lifetec's PB Ratio of today is 1.69.
The historical rank and industry rank for Savior Lifetec's PB Ratio or its related term are showing as below:
ROCO:4167'
s PB Ratio Range Over the Past 10 Years
Min: 1.32 Med: 2.16 Max: 4.85
Current: 1.7
During the past 13 years, Savior Lifetec's highest PB Ratio was 4.85. The lowest was 1.32. And the median was 2.16.
ROCO:4167's PB Ratio is ranked better than 69.06% of 1228
companies
in the Biotechnology industry
Industry Median: 2.885
vs ROCO:4167: 1.70
During the past 12 months, Savior Lifetec's average Book Value Per Share Growth Rate was 10.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 4.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 2.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Savior Lifetec was 13.90% per year. The lowest was -9.10% per year. And the median was 1.25% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Savior Lifetec PB Ratio Related Terms
Savior Lifetec PB Ratio Historical Data
* Premium members only.
The historical data trend for Savior Lifetec's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4167 vs VRTX, REGN, ALNY: PB Ratio Comparison
For the Biotechnology subindustry, Savior Lifetec's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Savior Lifetec PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Savior Lifetec's PB Ratio distribution charts can be found below:
* The bar in red indicates where Savior Lifetec's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Savior Lifetec's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Savior Lifetec (ROCO:4167) has a PB Ratio of 1.69 as of Jul. 14, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Savior Lifetec and its competitors. This is 22% below median its historical median of 2.16. Over the past decade, Savior Lifetec's PB Ratio has ranged from 1.32 to 4.85. According to the industry distribution chart, Savior Lifetec ranks #380 out of 1228 companies in the Biotechnology industry, placing it in the top 30.9%.
Is Savior Lifetec's PB Ratio too high?
Savior Lifetec's current PB Ratio of 1.69 is 22% below median its 10-year median of 2.16. Over the past 10 years, this metric has ranged from a low of 1.32 to a high of 4.85. The Biotechnology industry median PB Ratio is 2.89. Savior Lifetec's value of 1.69 is 41.4% below this industry median. Based on the distribution chart, Savior Lifetec ranks #380 out of 1228 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Savior Lifetec has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Savior Lifetec's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Savior Lifetec ranks #380 out of 1228 companies for PB Ratio. This puts Savior Lifetec in the upper half of its industry. The industry median PB Ratio is 2.89. Savior Lifetec's value of 1.69 is 41.4% below this benchmark. Historically, Savior Lifetec's own PB Ratio has ranged from 1.32 to 4.85 over the past decade. While the company's 10-year median is 2.16 vs. the industry median of 2.89, Savior Lifetec has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.89, based on 1,228 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Savior Lifetec's current PB Ratio of 1.69 is 41.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Savior Lifetec and its competitors. For the Biotechnology industry, the median PB Ratio is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Savior Lifetec's current PB Ratio is 1.69, which is 22% below median its own 10-year median of 2.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Savior Lifetec stock overvalued right now?
Based on GuruFocus' analysis, Savior Lifetec (ROCO:4167) is currently considered Fairly Valued. The stock's GF Value™ is NT$20.31, compared to a current price of NT$20.60 — trading 1.4% above its estimated fair value. The current PB Ratio is 1.69, which is 22% below median its 10-year median of 2.16 and 41.4% below the Biotechnology industry median of 2.89. Savior Lifetec's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Savior Lifetec (ROCO:4167), the current PB Ratio is 1.69 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Savior Lifetec (ROCO:4167) Overvalued in 2026?
Based on GuruFocus' analysis, Savior Lifetec stock appears to be overvalued.
The current stock price of NT$20.60 is trading 1.4% above its estimated GF Value™ of NT$20.31.
GuruFocus considers Savior Lifetec to be Fairly Valued.
Key valuation signals for ROCO:4167:
PB Ratio: 1.69 (22% below median its 10-year median of 2.16)
GF Value™: NT$20.31 vs. price of NT$20.60 (1.4% above fair value)
Industry Position: 41.4% below the Biotechnology median (#380 of 1228)
No single metric tells the full story. See the ROCO:4167 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions: the Americas, Asia, Taiwan, and Europe.
68GF Score
Get the complete analysis for ROCO:4167
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4167 has been successfully added to your 
